Envoy Medical Ownership | Who Owns Envoy Medical?
Envoy Medical Ownership Summary
Envoy Medical is owned by 9.80% institutional investors, 37.01% insiders, and 53.19% retail investors. Atlas merchant capital is the largest institutional shareholder, holding 2.60% of COCH shares.
COCH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Envoy Medical | 9.80% | 37.01% | 53.19% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Industry | Medical Device Stocks | 37.80% | 10.03% | 52.17% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Atlas merchant capital | 555.53K | 2.60% | $430.92K |
| Vanguard group | 339.11K | 1.59% | $263.15K |
| Weiss asset management lp | 242.64K | 1.13% | $188.22K |
| Colony group | 212.66K | 0.99% | $164.96K |
| Dsg capital advisors | 163.64K | 0.77% | $126.94K |
| Arcus capital partners | 152.87K | 0.71% | $118.58K |
| Cibc private wealth group | 77.89K | 0.36% | $110.60K |
| Morgan stanley | 56.50K | 0.26% | $43.83K |
| Geode capital management | 46.54K | 0.22% | $36.12K |
| Highpoint advisor group | 38.66K | 0.18% | $29.99K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas merchant capital | 555.53K | 0.19% | $430.92K |
| Arcus capital partners | 152.87K | 0.05% | $118.58K |
| Dsg capital advisors | 163.64K | 0.02% | $126.94K |
| Ballew advisors | 10.12K | 0.01% | $9.29K |
| Weiss asset management lp | 242.64K | 0.00% | $188.22K |
| Highpoint advisor group | 38.66K | 0.00% | $29.99K |
| Bluestem wealth partners | 10.45K | 0.00% | $8.11K |
| American capital advisory | 2.00K | 0.00% | $1.55K |
| Virtu financial | 13.89K | 0.00% | $11.00K |
| Colony group | 212.66K | 0.00% | $164.96K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Virtu financial | 13.89K | 0.00% | 13.89K |
| Northern trust | 26.39K | - | 12.35K |
| Ballew advisors | 10.12K | 0.01% | 10.12K |
| Ubs group | 24.10K | - | 10.03K |
| Morgan stanley | 56.50K | - | 5.56K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Northrock partners | - | - | -10.29M |
| Weiss asset management lp | 242.64K | 0.00% | -125.50K |
| Vanguard group | 339.11K | - | -55.85K |
| Geode capital management | 46.54K | - | -47.59K |
| Arcus capital partners | 152.87K | 0.05% | -34.70K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Virtu financial | 13.89K | 0.00% | 13.89K | $11.00K |
| Ballew advisors | 10.12K | 0.01% | 10.12K | $9.29K |
| Farther finance advisors | 3.00K | - | 3.00K | $2.33K |
| Barclays | 203.00 | - | 203.00 | $157.00 |
| Citigroup | 71.00 | - | 71.00 | $55.00 |
Sold Out
| Holder | Change |
|---|---|
| Jpmorgan chase | -19.00 |
| Northrock partners | -10.29M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 27 | 17.39% | 2,096,162 | -83.36% | 9 | 0.28% | 11 | 175.00% | 6 | 20.00% |
| Jun 30, 2025 | 23 | 4.55% | 12,596,501 | 446.87% | 58 | 50.50% | 4 | -42.86% | 5 | 25.00% |
| Mar 31, 2025 | 22 | -12.00% | 2,303,397 | 13.74% | 10 | 9.30% | 7 | -46.15% | 4 | 100.00% |
| Dec 31, 2024 | 25 | 38.89% | 2,025,076 | 96.05% | 10 | 38.87% | 13 | 62.50% | 2 | - |
| Sep 30, 2024 | 18 | -10.00% | 1,032,950 | -11.11% | 5 | 14.98% | 8 | -27.27% | 2 | -33.33% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 11, 2025 | Patel Mona Chetan | - | Buy | $3.67K |
| Jun 06, 2025 | Patel Mona Chetan | - | Buy | $14.60K |
| May 22, 2025 | BRYNELSEN CHARLES | - | Buy | $3.37K |
| May 23, 2025 | BRYNELSEN CHARLES | - | Buy | $21.36K |
| May 27, 2025 | BRYNELSEN CHARLES | - | Buy | $57.67K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2027 Q4 | - | - |
| 2024 Q3 | 2 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 1 | - |
| 2023 Q4 | 3 | - |
COCH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools